Blanket Purchase Agreement 47QRAA22D0055-75F40124A00002

This Blanket Purchase Agreement (BPA) was awarded by the U.S. Food and Drug Administration (FDA), a civilian agency under the Department of Health and Human Services, to Versar, Inc., a global project management company. The BPA has a ceiling value of $12.5M and runs through February 2029.

Under this BPA, Versar will provide peer review and scientific assessment support services to the FDA. Specific task orders include peer review of expert elicitation on food contaminants ($1.3M), and peer review and expert elicitation on FDA documents ($252,756). Versar has previously supported the FDA, EPA, and Army Corps of Engineers with technical and scientific assessments, demonstrating its expertise in areas like environmental consulting, risk assessment, and project engineering. The BPA was awarded under the Multiple Award Schedule (MAS) program, allowing the FDA to efficiently procure Versar's specialized services as needed. The contract does not have a set-aside designation.